Amedisys’ (AMED) Equal Weight Rating Reiterated at Stephens

Stephens restated their equal weight rating on shares of Amedisys (NASDAQ:AMED) in a research report released on Wednesday,Benzinga reports. They currently have a $101.00 target price on the health services provider’s stock.

Amedisys Stock Up 0.2 %

Shares of NASDAQ AMED opened at $92.66 on Wednesday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys has a 1 year low of $82.15 and a 1 year high of $98.95. The stock’s 50-day simple moving average is $89.82 and its 200-day simple moving average is $93.69. The firm has a market cap of $3.03 billion, a price-to-earnings ratio of 36.77, a PEG ratio of 1.82 and a beta of 0.73.

Hedge Funds Weigh In On Amedisys

Institutional investors have recently made changes to their positions in the business. Creative Planning boosted its stake in Amedisys by 7.4% during the 2nd quarter. Creative Planning now owns 4,295 shares of the health services provider’s stock valued at $394,000 after acquiring an additional 295 shares during the last quarter. CWM LLC raised its stake in shares of Amedisys by 14.5% in the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after purchasing an additional 277 shares in the last quarter. Inspire Investing LLC lifted its position in shares of Amedisys by 11.2% during the third quarter. Inspire Investing LLC now owns 4,250 shares of the health services provider’s stock worth $410,000 after purchasing an additional 428 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in shares of Amedisys by 6.4% during the third quarter. Exchange Traded Concepts LLC now owns 7,508 shares of the health services provider’s stock worth $725,000 after purchasing an additional 450 shares during the last quarter. Finally, Signaturefd LLC grew its stake in Amedisys by 20.9% in the third quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock worth $132,000 after purchasing an additional 236 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.